Kangmei Pharmaceutical Co Ltd Cash Flow Conversion Efficiency
Kangmei Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Kangmei Pharmaceutical Co Ltd (600518) has a cash flow conversion efficiency ratio of 0.030x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥219.96 Million ≈ $32.19 Million USD) by net assets (CN¥7.22 Billion ≈ $1.06 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Kangmei Pharmaceutical Co Ltd (1999–2024)
Cash flow conversion efficiency of Kangmei Pharmaceutical Co Ltd from 1999 to 2024. This chart illustrates how Kangmei Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 600518 live share price for real-time trading data and today's change.
Kangmei Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained
Kangmei Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Kangmei Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Kangmei Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see market cap of Kangmei Pharmaceutical Co Ltd for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Aoshikang Technology Co Ltd Class A
SHE:002913
|
-0.001x |
|
McGrath RentCorp
NASDAQ:MGRC
|
0.065x |
|
Caida Securities Co Ltd
SHG:600906
|
-0.139x |
|
Ruentex Development Co Ltd
TW:9945
|
0.017x |
|
Yongan Futures Co.Ltd.
SHG:600927
|
-0.027x |
|
LG Display Co Ltd
NYSE:LPL
|
-0.016x |
|
Cal-Comp Electronics (Thailand) Public Company Limited
BK:CCET
|
-0.031x |
|
Bumi Resources Tbk
JK:BUMI
|
-0.009x |
Annual Cash Flow Conversion Efficiency for Kangmei Pharmaceutical Co Ltd (1999–2024)
The table below shows the annual cash flow conversion efficiency of Kangmei Pharmaceutical Co Ltd from 1999 to 2024. Review 600518 free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥7.21 Billion ≈ $1.05 Billion |
CN¥-427.63 Million ≈ $-62.58 Million |
-0.059x | -32.28% |
| 2023-12-31 | CN¥7.08 Billion ≈ $1.04 Billion |
CN¥-317.52 Million ≈ $-46.46 Million |
-0.045x | +58.58% |
| 2022-12-31 | CN¥6.93 Billion ≈ $1.01 Billion |
CN¥-749.96 Million ≈ $-109.74 Million |
-0.108x | -603.84% |
| 2021-12-31 | CN¥9.97 Billion ≈ $1.46 Billion |
CN¥214.21 Million ≈ $31.34 Million |
0.021x | +121.69% |
| 2020-12-31 | CN¥-10.41 Billion ≈ $-1.52 Billion |
CN¥1.03 Billion ≈ $150.93 Million |
-0.099x | -171.00% |
| 2019-12-31 | CN¥20.65 Billion ≈ $3.02 Billion |
CN¥2.88 Billion ≈ $421.73 Million |
0.140x | +1092.59% |
| 2018-12-31 | CN¥26.12 Billion ≈ $3.82 Billion |
CN¥305.62 Million ≈ $44.72 Million |
0.012x | +106.89% |
| 2017-12-31 | CN¥28.52 Billion ≈ $4.17 Billion |
CN¥-4.84 Billion ≈ $-708.25 Million |
-0.170x | -411.09% |
| 2016-12-31 | CN¥29.38 Billion ≈ $4.30 Billion |
CN¥1.60 Billion ≈ $234.60 Million |
0.055x | +101.99% |
| 2015-12-31 | CN¥18.84 Billion ≈ $2.76 Billion |
CN¥508.86 Million ≈ $74.46 Million |
0.027x | -60.11% |
| 2014-12-31 | CN¥16.72 Billion ≈ $2.45 Billion |
CN¥1.13 Billion ≈ $165.68 Million |
0.068x | -51.33% |
| 2013-12-31 | CN¥12.03 Billion ≈ $1.76 Billion |
CN¥1.67 Billion ≈ $244.96 Million |
0.139x | +46.04% |
| 2012-12-31 | CN¥10.58 Billion ≈ $1.55 Billion |
CN¥1.01 Billion ≈ $147.55 Million |
0.095x | +53.26% |
| 2011-12-31 | CN¥9.25 Billion ≈ $1.35 Billion |
CN¥574.96 Million ≈ $84.14 Million |
0.062x | -54.24% |
| 2010-12-31 | CN¥4.93 Billion ≈ $720.79 Million |
CN¥669.19 Million ≈ $97.92 Million |
0.136x | +385.79% |
| 2009-12-31 | CN¥4.27 Billion ≈ $625.11 Million |
CN¥119.47 Million ≈ $17.48 Million |
0.028x | +2604.86% |
| 2008-12-31 | CN¥2.92 Billion ≈ $426.72 Million |
CN¥3.02 Million ≈ $441.19K |
0.001x | -98.52% |
| 2007-12-31 | CN¥2.32 Billion ≈ $339.36 Million |
CN¥162.55 Million ≈ $23.79 Million |
0.070x | +18.58% |
| 2006-12-31 | CN¥1.16 Billion ≈ $169.13 Million |
CN¥68.32 Million ≈ $10.00 Million |
0.059x | -74.53% |
| 2005-12-31 | CN¥573.59 Million ≈ $83.93 Million |
CN¥133.13 Million ≈ $19.48 Million |
0.232x | +51.30% |
| 2004-12-31 | CN¥511.88 Million ≈ $74.90 Million |
CN¥78.52 Million ≈ $11.49 Million |
0.153x | -13.01% |
| 2003-12-31 | CN¥442.44 Million ≈ $64.74 Million |
CN¥78.02 Million ≈ $11.42 Million |
0.176x | +29.03% |
| 2002-12-31 | CN¥391.23 Million ≈ $57.25 Million |
CN¥53.47 Million ≈ $7.82 Million |
0.137x | +218.04% |
| 2001-12-31 | CN¥365.10 Million ≈ $53.43 Million |
CN¥15.69 Million ≈ $2.30 Million |
0.043x | -55.15% |
| 2000-12-31 | CN¥103.96 Million ≈ $15.21 Million |
CN¥9.96 Million ≈ $1.46 Million |
0.096x | -64.81% |
| 1999-12-31 | CN¥111.12 Million ≈ $16.26 Million |
CN¥30.25 Million ≈ $4.43 Million |
0.272x | -- |
About Kangmei Pharmaceutical Co Ltd
Kangmei Pharmaceutical Co., Ltd. produces and sells Chinese herbal medicines in China. The company offers Chinese patent medicines, chemical medicines, and health food products. In addition, it engages in the operation of Chinese medicinal materials markets; production and sale of medical devices; and operation of pharmaceutical logistics system. The company provides its products through medical … Read more